The ongoing negotiations between the Latin American country of Peru and the American company Pfizer, which produces the Corona virus vaccine, have created a deadlock in the vaccine purchase. The issue of deadlock is such, which has caused concern all over the world. Peru has stated that the Pfizer company has prepared a contract for the sale of the vaccine, which includes a provision for legal immunity. According to this, if there is any side effect of the vaccine or if someone dies because of it, then no legal action can be taken against Pfizer.
With the introduction of the Pfizer company, Peru began negotiations with the company to purchase the vaccine. But the country’s Health Minister Pilar Majeti said in Peru’s parliament on Tuesday – we do not have some agreement on some points of agreement with Pfizer. These points are also related to the price and delivery schedule, but it is also related to some discounts being asked by the company. For example, the company is seeking immunity for judicial jurisdiction.
Majeti himself is a physician. She has been associated with the Health Administration in Peru for a long time. He said that such agreements are confidential. He said that for this reason, he is not in a position to give more information about the differences with Pfizer. Significantly, Peru announced the purchase of 10 million vaccines from Pfizer in November last. But when the company sent a draft agreement to the Peruvian government regarding this, the matter got stuck. Many Peruvian legal experts have said that no company can be given such immunity under Peruvian law.
However, the issue of legal immunity is not raised by Peru alone. Before this, President of Brazil, Jair Bolsonaro has also raised these questions. He said last month that it is clear that Pfizer does not want to take any responsibility. That is, if you are affected by any side effects, then this is your problem. Argentine authorities have also raised such concerns.
Pfizer vaccines have been approved in many countries. The World Health Organization has also given it the green signal. But there have also been reports of serious side effects emerging after vaccination from several countries. In Portugal this week, a person died shortly after being vaccinated. A few days after vaccination in Norway, there has been news of a person’s death. However, it is not clear whether those deaths were related to the vaccine.
There have also been clinical trials of vaccines of several other companies in Peru. These include Chinese company Sinopharm, UK-based AstraZeneca and American company Johnson & Johnson vaccines. But the conversation reached the forefront with the Pfizer company, in which now the deadlock on the issue of legal immunity has come.